ArticleJuntendo medical journal2026
Association of Sarcopenia and Bone Mineral Density in Patients with Chronic Liver Disease: A Prospective Cohort Study Using Standardised Scales.
Article in Juntendo medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Patients with chronic liver diseases (CLD) are likely to have low bone mineral density (BMD) and sarcopenia, complicating frailty, fractures, and death. However, this relationship is not appropriately studied among South Asian individuals. Objectives: The study aimed to establish the association between sarcopenia and BMD in CLD patients using standardised assessment tools. Methods: The proposed study is a prospective cohort study involving 501 adults with CLD in tertiary hospitals in Pakistan and collaborating international centers between December 2024 and July 2025. The baseline, 3 months and 6 months were used to determine the risk of sarcopenia and osteoporosis using the SARC-F and Osteoporosis Self-Assessment Tool for Asians (OSTA). Mann-Whitney U tests, repeated measures ANOVA and multiple linear regression were used to analyse data. Results: Men scored higher on SARC-F (p < 0.05), indicating a higher risk of sarcopenia, whereas women scored higher on OSTA (p < 0.05), indicating better bone health. Risks were also much higher at six months (F = 68.35 and 52.84, p < 0.001). Lower OSTA scores were predicted by higher SARC-F scores (B = -0.684, p < 0.001), older age, male sex, and longer disease duration, but physical activity was protective (B = 1.042, p < 0.001). Conclusion: The loss of BMD is closely associated with sarcopenia in CLD. The musculoskeletal deterioration and better outcomes in this high-risk population can be achieved through early screening and interventions to encourage physical activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.